Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
CA 2263143 A1 · Owner: Jimenez, Pablo · Inventors: Moore, Paul A.; Zhang, Jun; Duan, Roxanne
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to newly identified polynucleotides polypeptides , encoded by such polynucleotides the use of such polynucleotides and , polypeptides as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is a Keratinocyte Growth Factor, sometimes hereinafter referred to as "KGF-2" also formerly known as Fibroblast Growth Factor 12 (FGF-12). The invention also relates to inhibiting the action of such polypeptides. This invention further relates to the therapeutic use of KGF-2 to promote or accelerate wound healing. This invention also relates to novel mutant forms of KGF-2 that show enhanced activity, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 13, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 13, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 13, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.